文献速递关节外科

药物干预改善初次全关节置换术后睡眠质量的有限疗效:随机对照试验的系统综述与Meta分析

Limited Efficacy of Pharmacological Interventions for Improving Postoperative Sleep Quality in Primary Total Joint Arthroplasty Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
PubMed 文献 · J Arthroplasty · 2025-09-01

该系统综述与Meta分析纳入24项随机对照试验共2934例初次全关节置换患者,评估药物干预对术后睡眠质量的影响。唑吡坦显著改善主观睡眠质量(Hedges' g=-1.510,P<0.001)并改善术后3周内的客观睡眠参数,但常规使用受安全性和不良事件限制;褪黑素和皮质类药物获益极小或无;抗惊厥药改善睡眠评分但不良事件率更高。

要点

  • 唑吡坦显著改善全关节置换术后睡眠质量(Hedges' g=-1.510,P<0.001),并改善术后3周内客观睡眠参数。
  • 抗惊厥药显著改善睡眠评分(Hedges' g=-0.603,P<0.001),但不良事件率更高。
  • 褪黑素和皮质类药物对睡眠质量获益极小或无。

核心结论

  • 唑吡坦对全关节置换患者术后睡眠质量有显著短期改善,但常规使用受安全性和不良事件限制。
  • 褪黑素、皮质类药物和抗惊厥药的获益不一致,作者指出需要更严格、标准化和更长期的研究来确定改善术后恢复的最佳药物策略。

研究设计与样本

  • 系统综述与Meta分析,遵循PRISMA指南,方案注册于PROSPERO。
  • 检索PubMed、Embase、Scopus和Web of Science,检索日期为2024年10月5日,无语言或发表时间限制。
  • 纳入比较药物干预与常规术后护理的随机对照试验,共纳入24项研究、2934例患者。
  • 使用美国国立卫生研究院随机对照试验工具评估偏倚风险,采用GRADE方法评价证据确定性。

主要发现

  • 唑吡坦显著改善睡眠质量(Hedges' g=-1.510;P<0.001),并改善术后3周内的客观睡眠参数。
  • 抗惊厥药显著改善睡眠评分(Hedges' g=-0.603;P<0.001),但不良事件率更高。
  • 褪黑素和皮质类药物对睡眠质量获益极小或无。

局限性

  • 作者指出需要更严格、标准化和更长期的研究来确定改善术后恢复的最佳药物策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Sleep disturbances are common after total joint arthroplasty (TJA) and are associated with impaired recovery, increased complications, and prolonged hospital stays. Although various pharmacological interventions have been evaluated to improve postoperative sleep quality among TJA patients, consensus on their efficacy and safety remains elusive. METHODS: We conducted a systematic review and meta-analysis following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines and registered the protocol in the International Prospective Register of Systematic Reviews. A comprehensive search of PubMed, Embase, Scopus, and Web of Science was performed on October 5, 2024, with no language or publication date restrictions. Randomized controlled trials comparing pharmacological interventions versus routine postoperative care in TJA patients were included. Data on subjective sleep quality scores and objective measures like actigraphy and polysomnography were extracted, and the risk of bias was assessed using the National Institutes of Health randomized controlled trial tool. Certainty of evidence was evaluated using the Grading of Recommendations, Assessment, Development, and Evaluation approach. There were 24 studies involving 2,934 patients included. RESULTS: Meta-analysis revealed that zolpidem significantly improved sleep quality (Hedges' g = -1.510; P < 0.001) and enhanced objective sleep parameters up to three weeks postoperatively. Anticonvulsants significantly improved sleep scores (Hedges' g = -0.603; P < 0.001), although they were associated with higher adverse event rates. Melatonin and corticosteroids showed minimal or no benefit on sleep quality. CONCLUSIONS: Although zolpidem offers significant short-term improvements in postoperative sleep quality in TJA patients, its routine use is limited by safety concerns and adverse events. Melatonin, corticosteroids, and anticonvulsants provide inconsistent benefits, underscoring the need for more rigorous, standardized, and longer-term studies to establish optimal pharmacological strategies for enhancing postoperative recovery. LEVEL OF EVIDENCE: II.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Namazi N, Salmani A, Ayati A, et al. Limited Efficacy of Pharmacological Interventions for Improving Postoperative Sleep Quality in Primary Total Joint Arthroplasty Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Arthroplasty. 2025. PMID: 40902687. doi:10.1016/j.arth.2025.08.071

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。